# Oxaliplatin and Docetaxel Followed by Cetuximab for Head and Neck Cancer

> **NCT00591149** · PHASE2 · TERMINATED · sponsor: **University of Kansas Medical Center** · enrollment: 16 (actual)

## Conditions studied

- Head and Neck Cancer
- Carcinoma, Squamous

## Interventions

- **DRUG:** Oxaliplatin
- **DRUG:** Docetaxel
- **DRUG:** Cetuximab

## Key facts

- **NCT ID:** NCT00591149
- **Lead sponsor:** University of Kansas Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-06
- **Primary completion:** 2012-04
- **Final completion:** 2012-04
- **Target enrollment:** 16 (ACTUAL)
- **Why stopped:** Study was stopped due to termination of funding
- **Last updated:** 2017-06-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00591149

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00591149, "Oxaliplatin and Docetaxel Followed by Cetuximab for Head and Neck Cancer". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00591149. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*